Rhoen Klinikum AG
XETRA:RHK

Watchlist Manager
Rhoen Klinikum AG Logo
Rhoen Klinikum AG
XETRA:RHK
Watchlist
Price: 13.8 EUR 2.22%
Market Cap: 923.8m EUR
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+3%
Revenue
Forecast
+6%
Operating Income
Forecast
+12%
Net Income
Forecast
+9%

Wall Street
Price Targets

RHK Price Targets Summary
Rhoen Klinikum AG

Wall Street analysts forecast RHK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RHK is 14.28 EUR with a low forecast of 12.12 EUR and a high forecast of 16.8 EUR.

RHK Lowest Forecast
Wall Street Target
12.12 EUR
12% Downside
RHK Average Forecast
Wall Street Target
14.28 EUR
3% Upside
RHK Highest Forecast
Wall Street Target
16.8 EUR
22% Upside
Lowest
Price Target
12.12 EUR
12% Downside
Average
Price Target
14.28 EUR
3% Upside
Highest
Price Target
16.8 EUR
22% Upside
Rhoen Klinikum AG Competitors:
Price Targets
USPH
US Physical Therapy Inc
60% Upside
A
AEVS
Aevis Victoria SA
26% Upside
G
MEDANTA
Global Health Ltd
6% Upside
S
SHALBY
Shalby Ltd
48% Upside
USPH
US Physical Therapy Inc
60% Upside
A
AEVS
Aevis Victoria SA
26% Upside
G
MEDANTA
Global Health Ltd
6% Upside
S
SHALBY
Shalby Ltd
48% Upside
K
KPJ
KPJ Healthcare Bhd
10% Upside
PSQ
Pacific Smiles Group Ltd
3% Downside
MIKA
Mitra Keluarga Karyasehat Tbk PT
45% Upside
A50
Thomson Medical Group Ltd
14% Upside

Revenue
Forecast

Revenue Estimate
Rhoen Klinikum AG

For the last 8 years the compound annual growth rate for Rhoen Klinikum AG's revenue is 4%. The projected CAGR for the next 4 years is 6%.

4%
Past Growth
6%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Rhoen Klinikum AG

For the last 8 years the compound annual growth rate for Rhoen Klinikum AG's operating income is -10%. The projected CAGR for the next 4 years is 14%.

-10%
Past Growth
14%
Estimated Growth
Estimates Accuracy
12%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Rhoen Klinikum AG

For the last 8 years the compound annual growth rate for Rhoen Klinikum AG's net income is -9%. The projected CAGR for the next 4 years is 10%.

-9%
Past Growth
10%
Estimated Growth
Estimates Accuracy
21%
Average Beat
What are analyst estimates?

See Also

Summary
RHK intrinsic value, competitors valuation, and company profile.
DCF Valuation
RHK stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RHK stock valuation using valuation multiples.
Wall Street Estimates
RHK price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RHK stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RHK's stock price target?
Price Target
14.28 EUR

According to Wall Street analysts, the average 1-year price target for RHK is 14.28 EUR with a low forecast of 12.12 EUR and a high forecast of 16.8 EUR.

What is Rhoen Klinikum AG's Revenue forecast?
Projected CAGR
6%

For the last 8 years the compound annual growth rate for Rhoen Klinikum AG's revenue is 4%. The projected CAGR for the next 4 years is 6%.

What is Rhoen Klinikum AG's Operating Income forecast?
Projected CAGR
14%

For the last 8 years the compound annual growth rate for Rhoen Klinikum AG's operating income is -10%. The projected CAGR for the next 4 years is 14%.

What is Rhoen Klinikum AG's Net Income forecast?
Projected CAGR
10%

For the last 8 years the compound annual growth rate for Rhoen Klinikum AG's net income is -9%. The projected CAGR for the next 4 years is 10%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 243,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.